These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16275600)

  • 1. Activation of naloxone-sensitive and -insensitive inhibitory systems in a human pain model.
    Koppert W; Filitz J; Tröster A; Ihmsen H; Angst M; Flor H; Schüttler J; Schmelz M
    J Pain; 2005 Nov; 6(11):757-64. PubMed ID: 16275600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous pain inhibitory systems activated by spatial summation are opioid-mediated.
    Julien N; Marchand S
    Neurosci Lett; 2006 Jul; 401(3):256-60. PubMed ID: 16600506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of subcutaneous naloxone on experimentally induced pain.
    Robertson LJ; Hammond GR; Drummond PD
    J Pain; 2008 Jan; 9(1):79-87. PubMed ID: 17964860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.
    Pereira MP; Werner MU; Dahl JB
    Trials; 2015 Nov; 16():511. PubMed ID: 26554360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans.
    Koppert W; Angst M; Alsheimer M; Sittl R; Albrecht S; Schüttler J; Schmelz M
    Pain; 2003 Nov; 106(1-2):91-9. PubMed ID: 14581115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia.
    Chu LF; Dairmont J; Zamora AK; Young CA; Angst MS
    J Pain; 2011 Jan; 12(1):108-15. PubMed ID: 20864417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-insensitive hypoalgesia to mechanical stimuli at sites ipsilateral and contralateral to experimental muscle pain in human volunteers.
    Graven-Nielsen T; Gibson SJ; Laursen RJ; Svensson P; Arendt-Nielsen L
    Exp Brain Res; 2002 Sep; 146(2):213-22. PubMed ID: 12195523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose naloxone: Effects by late administration on pain and hyperalgesia following a human heat injury model. A randomized, double-blind, placebo-controlled, crossover trial with an enriched enrollment design.
    Springborg AD; Jensen EK; Kreilgaard M; Petersen MA; Papathanasiou T; Lund TM; Taylor BK; Werner MU
    PLoS One; 2020; 15(11):e0242169. PubMed ID: 33180816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose adenosine infusion provokes oscillations of chest pain without correlation to opioid modulation: a double-blind controlled study.
    Sadigh-Lindell B; Sylvén C; Berglund M; Eriksson BE
    J Pain; 2004 Nov; 5(9):469-75. PubMed ID: 15556824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients.
    Bijur PE; Schechter C; Esses D; Chang AK; Gallagher EJ
    J Pain; 2006 Feb; 7(2):75-81. PubMed ID: 16459272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone increases pain induced by topical capsaicin in healthy human volunteers.
    Anderson WS; Sheth RN; Bencherif B; Frost JJ; Campbell JN
    Pain; 2002 Sep; 99(1-2):207-16. PubMed ID: 12237198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of target-controlled infusion of high-dose naloxone on pain and hyperalgesia in a human thermal injury model: a study protocol: A randomized, double-blind, placebo-controlled, crossover trial with an enriched design.
    Springborg AD; Jensen EK; Taylor BK; Werner MU
    Medicine (Baltimore); 2016 Nov; 95(46):e5336. PubMed ID: 27861362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional magnetic resonance imaging navigated repetitive transcranial magnetic stimulation study of the posterior parietal cortex in normal pain and hyperalgesia.
    Seifert F; Fuchs O; Nickel FT; Garcia M; Dörfler A; Schaller G; Kornhuber J; Sperling W; Maihöfner C
    Neuroscience; 2010 Oct; 170(2):670-7. PubMed ID: 20643193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone antagonizes the local antihyperalgesic effect of fentanyl in burnt skin of healthy humans.
    Robertson LJ; Drummond PD; Hammond GR
    J Pain; 2007 Jun; 8(6):489-93. PubMed ID: 17368995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous opiates and the placebo effect: a meta-analytic review.
    Sauro MD; Greenberg RP
    J Psychosom Res; 2005 Feb; 58(2):115-20. PubMed ID: 15820838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychophysics, flare, and neurosecretory function in human pain models: capsaicin versus electrically evoked pain.
    Geber C; Fondel R; Krämer HH; Rolke R; Treede RD; Sommer C; Birklein F
    J Pain; 2007 Jun; 8(6):503-14. PubMed ID: 17434803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does naloxone reinstate secondary hyperalgesia in humans after resolution of a burn injury? A placebo-controlled, double-blind, randomized, cross-over study.
    Pereira MP; Werner MU; Ringsted TK; Rowbotham MC; Taylor BK; Dahl JB
    PLoS One; 2013; 8(5):e64608. PubMed ID: 23741350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans.
    Koppert W; Wehrfritz A; Körber N; Sittl R; Albrecht S; Schüttler J; Schmelz M
    Pain; 2004 Mar; 108(1-2):148-53. PubMed ID: 15109518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microinjection of morphine into thalamic nucleus submedius depresses bee venom-induced inflammatory pain in the rat.
    Feng J; Jia N; Han LN; Huang FS; Xie YF; Liu J; Tang JS
    J Pharm Pharmacol; 2008 Oct; 60(10):1355-63. PubMed ID: 18812029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.